We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688521:SSEVeriSilicon Microelectronics (Shanghai) Co., Ltd. Class A Analysis

Data as of 2026-09-01 - not real-time

CN¥194.01

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At ¥194.01, VeriSilicon Microelectronics (Shanghai) Co., Ltd. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it lost 20.7%. RSI sits at 46.4, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near ¥161.37 and resistance around ¥231.97.
The shares look overvalued, trading on 1055.7 times earnings above a sector average of 35.8. Sell-side targets cluster 40.1% above the current quote. Revenue is growing at 76.0% on a -20.3% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 107.1%, a beta of 1.25 and a maximum drawdown of 55.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.

Top Market Events

Design And Reuse - Catalog of IP Cores and Silicon on Chip solutions for IoT, Automotive, Security, RISC-V, AI, .Design And Reuse - Catalog of IP Cores and Silicon on Chip solutions for IoT, Automotive, Security, RISC-V, AI, .Design And Reuse - Catalog of IP Cores and Silicon on Chip solutions for IoT, Automotive, Security, RISC-V, AI, .

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 215.89
  • MACD momentum is positive
  • 30-day price change of -20.7%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 1055.7 versus sector average of 35.8
  • Trading below the 200-day average of 215.89
  • Analyst targets imply +40.1% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 1055.7 versus sector average of 35.8
  • Negative profit margin of -20.3%
  • Analyst targets imply +40.1% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth76.00%
Profit Margin-20.29%
P/E Ratio1055.7
ROE-25.12%
ROA-6.35%
Debt/Equity55.75
P/B Ratio34.9
Op. Cash FlowCN¥769.3M
Free Cash FlowCN¥582.8M
Industry P/E35.8

Technical Analysis

TrendNeutral
RSI46.4
SupportCN¥161.37
ResistanceCN¥231.97
MA 20CN¥199.10
MA 50CN¥239.60
MA 200CN¥215.89
MACDBullish
VolumeStable
Fear & Greed Index94.79

Valuation

Fair ValueCN¥40.15
Target PriceCN¥271.82
Upside/Downside40.11%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.25
Volatility107.10%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.